NORML’s 2016 Conference And Lobby Day – A Debrief

By Danielle Keane, NORML Political Director NORML members, supporters, and chapter leaders gathered in our nation’s capital this week, for NORML’s 2016 Conference and Lobby Day. The events were filled with education, activism, socializing, and plenty of marijuana smoking. For those who weren’t able to attend, keep reading below to find…

Continue reading

The Clock Is Ticking: Register to Attend NORML’s 2016 Conference and Congressional Lobby Day

By Danielle Keane, NORML Political Director We are ten days out from NORML’s 2016 Conference and Congressional Lobby Day and we are excited to share with you the full itinerary! Have you registered to attend? We have some fun events planned and it would be a shame for you to miss…

Continue reading

Early Registration Now Open For NORML’s Congressional Lobby Day 2016

By Danielle Keane, NORML Political Director If you are planning on attending this year’s Congressional Lobby Day in Washington D.C. this May 23rd and 24th and you like saving money, please take advantage of the early bird discount for pre-registering that is now available! The schedule will be released soon…

Continue reading

Congratulations To Trista Okel And Lindsey Rinehart For Joining Portland NORML’s Board Of Directors

Two amazing activists have joined the Portland NORML Board of Directors, and I wanted to personally thank them and congratulate them. I have never met Trista Okel, but I have heard a lot of good things about her and know that she has worked very hard over the years to…

Continue reading

NORML’s 2015 Congressional Letter Writing Campaign

By Kevin Mahmalji, NORML Outreach Coordinator Beginning on Monday, October 26, 2015, NORML Affiliates and Chapters from across the country will begin contacting their representatives to urge them to support one of the seventeen marijuana-related bills introduced since the 114th Congress convened on January 3, 2015. Over the past few…

Continue reading

NORML’s Emerging Clinical Applications For Cannabis And Cannabinoids

By Paul Armentano, NORML Deputy Director NORML is pleased to present the latest expanded/updated edition of the publication Emerging Clinical Applications for Cannabis & Cannabinoids — a comprehensive review of the latest peer-reviewed science specific to the safety and therapeutic efficacy of whole-plant cannabis and/or its components. The 2015 updated…

Continue reading